CFDE Data Portal | Search CSRP2

	Label	Description
	CSRP2 Gene (Entity type)	ENSG00000175183 - cysteine and glycine rich protein 2
	CSRP2 associations Collection (Entity type)	Associations for CSRP2_associations
	CSRP2 Up Gene Set (Entity type)	A Gene Set from LINCS
	CSRP2 Down Gene Set (Entity type)	A Gene Set from LINCS
	CSRP2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PAFAH1B3 Gene (Entity type)	ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3
	CAD Gene (Entity type)	ENSG00000084774 - carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
	GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

CSRP2

ENSG00000175183 - cysteine and glycine rich protein 2

CSRP2 associations

Associations for CSRP2_associations

CSRP2 Up

A Gene Set from LINCS

CSRP2 Down

A Gene Set from LINCS

CSRP2 associations.tsv

A file from IDG as part of the Harmonizome project

PAFAH1B3

ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3

CAD

ENSG00000084774 - carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE120612 etoposide leukocyte 6 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.